REFERENCES
1.2.3.4.5.
HerrK.Painassessmentstrategiesinolderpatients.JPain2011;12:S3–13.
PiazzaResearchandAlzheimer’sAustralia.Endoflifecareforpeoplewithdementia.Canberra:Alzheimer’sAustralia,2014.ScherderE,HerrK,PickeringG,etal.Painindementia.Pain2009;145:276–8.
ScherderEJ,BoumaA.IsdecreaseduseofanalgesicsinAlzheimerdiseaseduetoachangeintheaffectivecomponentofpain?AlzheimerDisAssocDisord1997;11:171–4.
SchmaderKE,HanlonJT,FillenbaumGG,etal.Medicationusepatternsamongdemented,cognitivelyimpairedandcognitivelyintactcommunity-dwellingelderlypeople.AgeAgeing1998;27:493–501.
TanECK,JokanovicN,KoponenMP,etal.Analgesicuseandpaininpeoplewithandwithoutdementiaorcognitiveimpairmentinagedcarefacilities:asystematicreviewandmeta-analysis.CurrClinPharmacol2014;inpress.
KunikME,CullyJA,SnowAL,etal.TreatablecomorbidconditionsanduseofVAhealthcareservicesamongpatientswithdementia.PsychiatrServ2005;56:70–5.
KunikME,SnowAL,DavilaJA,etal.Causesofaggressivebehaviorinpatientswithdementia.JClinPsychiatry2010;71:1145–52.CordnerZ,BlassDM,RabinsPV,etal.Qualityoflifeinnursinghomeresidentswithadvanceddementia.JAmGeriatrSoc2010;58:2394–400.
BallardC,HanneyML,TheodoulouM,etal.Thedementia
antipsychoticwithdrawaltrial(DART-AD):long-termfollow-upofarandomisedplacebo-controlledtrial.LancetNeurol2009;8:151–7.HartikainenS,LonnroosE,LouhivuoriK.Medicationasariskfactorforfalls:criticalsystematicreview.JGerontolABiolSciMedSci2007;62:1172–81.
MitchellSJ,HilmerSN,McLachlanAJ.Clinicalpharmacologyofanalgesicsinoldageandfrailty.RevClinGerontol2009;19:103–18.
McLachlanAJ,HilmerSN,LeCouteurDG.Variabilityinresponsetomedicinesinolderpeople:phenotypicandgenotypicfactors.ClinPharmacolTher2009;85:431–3.
HilmerSN,GnjidicD.Theeffectsofpolypharmacyinolderadults.ClinPharmacolTher2009;85:86–8.
BellJS,LaitinenML,LavikainenP,etal.Useofstrongopioidsamongcommunity-dwellingpersonswithandwithoutAlzheimer’sdiseaseinFinland.Pain2011;152:543–7.
MurnionBP,GnjidicD,HilmerSN.Prescriptionandadministrationofopioidstohospitalin-patients,andbarrierstoeffectiveuse.PainMed2010;11:58–66.
SchneiderLS,DagermanKS,InselP.Riskofdeathwithatypicalantipsychoticdrugtreatmentfordementia:meta-analysisofrandomizedplacebo-controlledtrials.JAMA2005;294:1934–43.HuseboBS,BallardC,SandvikR,etal.Efficacyoftreatingpaintoreducebehaviouraldisturbancesinresidentsofnursinghomeswithdementia:clusterrandomisedclinicaltrial.BMJ2011;343:d4065.PautexS,MichonA,GuediraM,etal.Paininseveredementia:self-assessmentorobservationalscales?JAmGeriatrSoc2006;54:1040–5.
WardenV,HurleyAC,VolicerL.DevelopmentandpsychometricevaluationofthePainAssessmentinAdvancedDementia(PAINAD)scale.JAmMedDirAssoc2003;4:9–15.
InternationalAssociationfortheStudyofPain.FacesPainScale—Revised.2012.doc.guandang.net
TheAnatomicalTherapeuticChemicalClassificationSystem.doc.guandang.net
SloaneP,IveyJ,RothM,etal.Accountingforthesedativeandanalgesiceffectsofmedicationchangesduringpatientparticipationinclinicalresearchstudies:measurementdevelopmentandapplicationtoasampleofinstitutionalizedgeriatricpatients.ContempClinTrials2008;29:140–8.
TaipaleHT,BellJS,SoiniH,etal.Sedativeloadandmortalityamongresidentsoflong-termcarefacilities:aprospectivecohortstudy.DrugsAging2009;26:871–81.
PaseroC,McCafferyM.Monitoringsedation.AmJNurs2002;102:67–9.
NisbetAT,Mooney-CotterF.Comparisonofselectedsedationscalesforreportingopioid-inducedsedationassessment.PainManagNurs2009;10:154–64.
27.28.29.30.31.32.
LeeJH,BliwiseDL,AnsariFP,etal.Daytimesleepinessand
functionalimpairmentinAlzheimerdisease.AmJGeriatrPsychiatry2007;15:620–6.
O’SuilleabhainPE,DeweyRBJr.ContributionsofdopaminergicdrugsanddiseaseseveritytodaytimesleepinessinParkinsondisease.ArchNeurol2002;59:986–9.
LatimerHillE,CummingRG,LewisR,etal.Sleepdisturbancesandfallsinolderpeople.JGerontolABiolSciMedSci2007;62:62–6.StGeorgeRJ,DelbaereK,WilliamsP,etal.Sleepqualityandfallsinolderpeoplelivinginself-andassisted-carevillages.Gerontology2009;55:162–8.
ClarkCM,EwbankDC.Performanceofthedementiaseverityratingscale:acaregiverquestionnaireforratingseverityinAlzheimerdisease.AlzheimerDisAssocDisord1996;10:31–9.WoodS,CummingsJL,HsuMA,etal.Theuseoftheneuropsychiatricinventoryinnursinghomeresidents.
Characterizationandmeasurement.AmJGeriatrPsychiatry2000;8:75–83.
CummingsJL,MegaM,GrayK,etal.Theneuropsychiatricinventory:comprehensiveassessmentofpsychopathologyindementia.Neurology1994;44:2308–14.
EdelmanP,FultonBR,KuhnD,etal.Acomparisonofthree
methodsofmeasuringdementia-specificqualityoflife:perspectivesofresidents,staff,andobservers.Gerontologist2005;45(SpecNo1):27–36.
LogsdonRG,GibbonsLE,McCurrySM,etal.Assessingqualityoflifeinolderadultswithcognitiveimpairment.PsychosomMed2002;64:510–19.
BeerC,FlickerL,HornerB,etal.Factorsassociatedwithselfandinformantratingsofthequalityoflifeofpeoplewithdementialivingincarefacilities:acrosssectionalstudy.PLoSONE2010;5:e15621.ReeveE,ShakibS,HendrixI,etal.Developmentandvalidationofthepatients’attitudestowardsdeprescribing(PATD)questionnaire.IntJClinPharm2013;35:51–6.
DementiaOutcomesMeasurementSuite.doc.guandang.net
GuigozY,LauqueS,VellasBJ.Identifyingtheelderlyatriskformalnutrition.TheMiniNutritionalAssessment.ClinGeriatrMed2002;18:737–57.
KaiserMJ,BauerJM,RamschC,etal.ValidationoftheMiniNutritionalAssessmentshort-form(MNA-SF):apracticaltoolforidentificationofnutritionalstatus.JNutrHealthAging2009;13:782–8.
JyrkkaJ,MursuJ,EnlundH,etal.Polypharmacyandnutritionalstatusinelderlypeople.CurrOpinClinNutrMetabCare2012;15:1–6.
KatzS,FordAB,MoskowitzRW,etal.Studiesofillnessintheaged.TheindexofADL:astandardizedmeasureofbiologicalandpsychosocialfunction.JAMA1963;185:914–19.
GrollDL,ToT,BombardierC,etal.Thedevelopmentofa
comorbidityindexwithphysicalfunctionastheoutcome.JClinEpidemiol2005;58:595–602.
LauDT,KasperJD,PotterDE,etal.Hospitalizationanddeathassociatedwithpotentiallyinappropriatemedicationprescriptionsamongelderlynursinghomeresidents.ArchInternMed2005;165:68–74.
SomersM,RoseE,SimmondsD,etal.Qualityuseofmedicinesinresidentialagedcare.AustFamPhysician2010;39:413–16.
StaffordAC,AlswayanMS,TenniPC.InappropriateprescribinginolderresidentsofAustraliancarehomes.JClinPharmTher2011;36:33–44.
KarttunenK,KarppiP,HiltunenA,etal.NeuropsychiatricsymptomsandqualityoflifeinpatientswithverymildandmildAlzheimer’sdisease.IntJGeriatrPsychiatry2011;26:473–82.
ZhangJ,YuKF.What’stherelativerisk?Amethodofcorrectingtheoddsratioincohortstudiesofcommonoutcomes.JAMA1998;280:1690–1.
JanssenKJ,DondersAR,HarrellFEJr,etal.Missingcovariatedatainmedicalresearch:toimputeisbetterthantoignore.JClinEpidemiol2010;63:721–7.
GnjidicD,HilmerSN,BlythFM,etal.High-riskprescribingandincidenceoffrailtyamongoldercommunity-dwellingmen.ClinPharmacolTher2012;91:521–8.
NationalStatementforEthicalConductinHumanResearch.doc.guandang.net
6.
7.8.9.10.11.12.13.14.15.16.17.18.19.20.21.22.23.
33.34.
35.36.37.38.39.40.
41.42.43.44.
45.46.47.48.49.50.51.
24.25.26.
6
TanECK,VisvanathanR,HilmerSN,etal.BMJOpen2014;4:e005757.doi:10.1136/bmjopen-2014-005757

and the VAS and FACES scale for pain assessment Ramsay Scale Sedation level...concomitant analgesic use as well as whether they have been anesthetized and...
Clinical practice guidelines for the sustained use ...Fentanyl Dormicum Morphine Sedation + pain control ...Better match between analgesic and psychoactive ...
selective α2-adrenergic agonist with sedative, anxiolytic, and analgesic ...Pain and sedation management in the critically ill child. In: Nichols DG,...
Fentanyl drip 25 – 100 mcg/min – titrate for sedation/pain ? Propofol ...hypnotic and analgesic with single agent Rapid onset: 6 min Elimination: 2...
Sedation and Anesthesia Learning OutcomesSedation and...Caution with geriatrics and pediatrics; use a ...Also classified according to their analgesic ...
alpha-2 adrenoreceptor agonist with sedative, analgesic and anxiolytic ...and patients who need sedation and/or analgesia for invasive and noninvasive...
Sedation and analgesia Sedation is achieved with the use of sedatives and ...The analgesic is included to reduce patient discomfort during block ...
remained sedated and comfortable, with a pain score of 0 ? 10 in the ?...ICU sedation, it is used peri-operatively for its analgesic effect [8]. ...
use the smallest dose of analgesic that provides effective pain control with...Sedation镇静 Sedation镇静 and respiratory depression (naloxone is an opioid ...
A continuous infusion of sedatives and analgesic drugs (dexmedetomidine, ...use (< or ? 24 h) to provide sedation in adults in the ICU, ...
热门文档